Approval · Notice of Compliance 14687 · 2013
TYBOST: Notice of Compliance 14687
Issued August 27, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14687
- Date
- August 27, 2013
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Pharmacokinetic enhancer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYBOST | 02411423 | Cancelled Post Market |
Medicinal ingredients
- COBICISTAT 150 MG per TAB